Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma
https://www.globenewswire.com/news-release/2022/05/20/2447571/0/en/ASLAN-Pharmaceuticals-Presents-Late-Breaking-Poster-on-Eblasakimab-and-Neuronal-Itch-Mechanisms-at-the-2022-Society-for-Investigative-Dermatology-Annual-Meeting.html
May 20, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next